Skip to content

Improving cognitive behavioural therapy for panic by identifying the active ingredients and understanding the mechanisms of action: a multicentre study

Improving cognitive behavioural therapy for panic by identifying the active ingredients and understanding the mechanisms of action: a multicentre study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN80046034
Enrollment
450
Registered
2007-02-21
Start date
2007-05-01
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Panic disorder with and without agoraphobia Mental and Behavioural Disorders Panic disorders

Interventions

Two treatment conditions are compared, both of them state-of-the-art-CBT: Condition A: CBT for panic disorder with therapist-guided in-vivo exposure exercises (in-vivo cBT-group)

Sponsors

German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Outpatients 2. 18 to 65 years old 3. Meet current Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) criteria of panic disorder with/without agoraphobia 4. Hamilton Anxiety Scale (HAMA) score more than or equal to 18 and a Clinical Global Impressions scale (CGI) score more than or equal to four 5. Able to attend clinic on his/her own or accompanied by significant others 6. Informed consent to participate and follow study procedures

Exclusion criteria

Exclusion criteria: 1. DSM-IV Axis I diagnoses of any psychotic disorder, bipolar disorder, current alcohol or drug dependence and Axis II of borderline personality disorder 2. DSM-IV Axis I disorders (other than panic disorder and agoraphobia) currently treated either by medications or non-pharmacological intervention 3. Acute suicidality (Composite International Diagnostic Interview [CIDI] scale 2+) 4. General medical contraindications

Design outcomes

Primary

MeasureTime frame
1. Number of panic attacks/month 2. Aggregated Panic Disorder Scale and Mobility Inventory (PDS-MI) score (panic severity plus avoidance) 3. Hamilton Anxiety Rating Scale

Secondary

MeasureTime frame
1. Depressive symptoms 2. Anticipatory anxiety in dark room-challenge and time in darkroom 3. Psychophysiological parameters 4. Neuroimaging parameters 5. Ecological Momentary Assessment (EMA) parameters

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 17, 2026